Will Medicare cover Zepbound and other weight loss drugs in 2026?

Answered by 10 licensed agents

Yes, but it is important to understand that this is not blanket coverage for everyone.

Starting July 1, 2026, Medicare is expected to provide access to certain GLP-1 weight loss drugs through what is called the Medicare GLP-1 Bridge program. This would apply to eligible people who have Medicare Part D coverage.

The drugs currently listed under this program include Foundayo, Wegovy, and Zepbound. For Zepbound, Medicare specifically lists the Zepbound KwikPen, not the single-dose vials or pens.

This is also a temporary program. It is scheduled to run from July 1, 2026 through December 31, 2027. One important detail is that this program operates outside the normal Part D payment system, which means Part D plans do not have to opt in for eligible beneficiaries to access the program.

The expected cost is a $50 copay for a one-month supply. However, that $50 does not count toward the Part D deductible or the annual out-of-pocket limit, and it cannot be reduced by Extra Help or LIS.

The biggest thing to understand is that eligibility is not simply based on wanting to lose weight. A provider would need to submit a prior authorization, and the patient would need to meet certain clinical requirements.

Those requirements may include BMI levels along with specific health conditions. For example, someone may qualify based on a BMI of 35 or higher, a BMI of 30 or higher with certain conditions such as heart failure, uncontrolled hypertension, or chronic kidney disease, or a BMI of 27 or higher with conditions such as prediabetes, a prior heart attack, prior stroke, or peripheral artery disease.

It is also important to separate weight loss coverage from coverage for another medical diagnosis. If a GLP-1 medication is prescribed for a Medicare-coverable diagnosis, such as Type 2 diabetes, obstructive sleep apnea, or MASH, that would generally be reviewed through the person’s regular Part D plan, not the GLP-1 Bridge program.

So the short answer is yes, but not for everyone.

Answered by Matt Maresch on June 24, 2026

Agent Licensed in TX

Answered by Matt Maresch Medicare Insurance Agent
Yes! Beginning July 1, 2026, Medicare started offering coverage for certain weight-loss medications, including Zepbound, Wegovy, and Foundayo, through a new program called the Medicare GLP-1 Bridge.

Eligible Medicare beneficiaries can receive these medications for **$50 per month**, but there are specific requirements.

To qualify, you must have Medicare Part D prescription drug coverage and meet certain medical criteria, such as:

- A BMI of 35 or higher.

- A BMI of 30 or higher with certain medical conditions, such as uncontrolled high blood pressure, heart failure, or chronic kidney disease.

- A BMI of 27 or higher with certain conditions, including prediabetes or a history of heart attack or stroke.

Your doctor must prescribe the medication and obtain prior authorization.

It's important to understand that not everyone will qualify, and only certain versions of these medications are covered. The program is currently scheduled to continue through December 31, 2027.

If you're interested, I recommend speaking with your doctor to determine whether you meet the requirements.

Answered by Dustin Haffner on November 16, 2026

Agent Licensed in OK, AR, KS & MO

Answered by Dustin Haffner Medicare Insurance Agent
Here is an email I recently sent my clients: Starting July 1, 2026, Medicare is launching the GLP-1 Bridge Program, which for the first time ever allows eligible Medicare members to access FDA-approved weight-loss medications at just $50/month. The covered drugs are Wegovy®, Zepbound® (KwikPen®), and Foundayo®.

To qualify, you generally need to:

• Be enrolled in a Medicare Part D or Medicare Advantage plan with drug coverage

• Need the medication for weight loss (not for diabetes or another condition)

• Meet clinical criteria set by your doctor

• Have your doctor submit a prior authorization through the Bridge Program

This program runs through December 31, 2027 and operates separately from your regular Part D plan.

If you think you might qualify or just want to talk through whether this applies to your situation, please don’t hesitate to reach out. I’m happy to help!

Answered by Ali Hall on June 29, 2026

Broker Licensed in FL, AZ, CA & 10 other states

Answered by Ali Hall Medicare Insurance Agent
Yes, in a limited way. Traditional Medicare law still excludes weight-loss drugs, but a temporary program changed that this year.

Starting July 1, 2026, Medicare covers certain GLP-1 drugs under the Medicare GLP-1 Bridge program. The covered drugs are Foundayo tablets, Wegovy as an injection or tablet, and Zepbound in the KwikPen only. The single-dose Zepbound pen and the vials are not covered.

Your cost is $50 per month, no matter your income level. You need to be in a Part D plan, and your prescriber has to get prior authorization and you must meet the eligibility criteria set by CMS.

Answered by Jose Ossorio on November 9, 2026

Agent Licensed in FL, AR, NC, OH, SC & TX

Answered by Jose Ossorio Medicare Insurance Agent
Starting July 1, 2026, Medicare will be running an 18-month program which will cover GLP-1s for weight loss. The covered drugs are Wegovy, Zepbound, and Foundayo. The copay will be $50 for eligible beneficiaries, and this is being handled outside of your Part D coverage, so none of the costs go toward your $2,100 TrOOP. Talk to your PCP or go to Medicare.gov to get more information. Note that requests cannot be submitted before July 1st.

Answered by Rich Baker on June 24, 2026

Broker Licensed in CO, AR, AZ & 9 other states

Answered by Rich Baker Medicare Insurance Agent
Yes, for many people, beginning July 1, 2026, Medicare will provide access to Zepbound, Wegovy, and certain other GLP-1 weight-loss medications through the new Medicare GLP-1 Bridge program. Eligibility requirements apply, including having Medicare Part D and meeting the program's medical criteria.

Answered by Mary Brown on June 29, 2026

Broker Licensed in NJ, DE, FL & 5 other states

Answered by Mary Brown Medicare Insurance Agent
Yes, starting July 1, 2026, Zepbound (KwikPen) and Wegovy will be covered for weight loss under the temporary Medicare GLP-1 Bridge Program for a fixed $50 monthly copay.

Answered by Vernon Jones on June 27, 2026

Broker Licensed in NC & SC

Answered by Vernon Jones Medicare Insurance Agent
Medicare generally does NOT cover Zepbound, Wegovy, or similar weight loss medications when they’re prescribed just for weight loss.

Medicare may cover Zepbound or similar medications if your doctor prescribes them for an FDA-approved medical condition, such as:

>Type 2 diabetes

>Obstructive sleep apnea (in some cases)

>Reducing cardiovascular risk

NOTE: In these situations, coverage depends on your specific Part D plan and whether the drug is on the formulary.

Bottom Line:

Pure weight loss = Not covered

Weight loss + another qualifying condition = Possibly covered

Answered by James Hale on June 26, 2026

Broker Licensed in GA, AL, FL & 5 other states

Answered by James Hale Medicare Insurance Agent
Medicare is introducing a trial program, GLP-1 Bridge, from 07/01/2026 to 12/31/2027.

For the treatment of obesity and weight loss, you may be eligible to have Foundayo (tablet), Wegovy (injection or tablet) and Zepbound Kwikpen (injection) with a $50 copay.

If the pharmacy bills your drug plan, it will be rejected.

Answered by Kristina Guerry on June 25, 2026

Broker Licensed in SC, AL, AR & 45 other states

Answered by Kristina Guerry Medicare Insurance Agent
Medicare GLP-1s.

Beginning July 1, 2026, Medicare will make certain GLP-1 medications available to eligible Medicare Part D policyholders for the treatment of obesity and weight loss under the Bridge Program. This is a temporary in that will run through December 31, 2027.

Medicare will manage this program. This is separate from the Medicare Beneficiary’s Medicare Part D coverage.

Source: Anthem BC/BS Medicare.

Answered by Andrew Zurbuch, MBA on June 24, 2026

Broker Licensed in IN, FL, KY, MO, OH & TN

Answered by Andrew Zurbuch, MBA Medicare Insurance Agent

Tags: Coverage Medicare Part D Prescription Drug

Agents: Share Your Expertise

Have insights or experiences related to this topic? Help others by sharing your knowledge and answering this question.

Seniors: Ask a Question of Your Own

Questions are generally answered within 1 to 3 business days. Receive valuable perspectives from multiple licensed agents and brokers.

Ask a Question